Biora Therapeutics
(OTC) BIORQ
Biora Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.76M
Net Income (TTM)
$31.54M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$0.00
Volume
60
Open
$0.00
Price
$0.00
Volume
60
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.34
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$0.00
Volume
60
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.34
BIORQ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biora Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
58
CEO
Adi Mohanty, MBA
Website
www.bioratherapeutics.comHeadquarters
San Diego, CA 92122, US
BIORQ Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-16786%
Net Income Margin
-31029%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
4.52M
Volume
60
Short Interest
0.00%
Avg. Volume
86.516
Financials (TTM)
Gross Profit
$4.00K
Operating Income
$67.14M
EBITDA
$114.05M
Operating Cash Flow
$48.50M
Capital Expenditure
$103.00K
Free Cash Flow
$48.60M
Cash & ST Invst.
$15.21M
Total Debt
$47.43M
Biora Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$32.00K
N/A
Gross Profit
$32.00K
+125.6%
Gross Margin
100.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
58
N/A
Net Income
$18.40M
+74.9%
EBITDA
$16.23M
+77.1%
Quarterly Fundamentals
Net Cash
$36.45M
+47.8%
Accounts Receivable
$868.00K
+6.1%
Inventory
$0.00
N/A
Long Term Debt
$14.68M
-82.0%
Short Term Debt
$24.96M
+2495.1%
Return on Assets
-3.98%
N/A
Return on Invested Capital
2.11%
N/A
Free Cash Flow
$31.95M
+389.5%
Operating Cash Flow
$31.82M
+388.4%